Dr James Cooney
Honorary (Fellow)
Department of Medical Biology (WEHI)
27 Scholarly works
0 Projects
HIGHLIGHTS
2026
Journal article
Preclinical development of a cross-protective β-SARS-CoV-2 virus-like particle vaccine adjuvanted with MF59
DOI: 10.1038/s41541-025-01355-y2025
Journal article
A novel chimeric coronavirus spike vaccine combining SARS-CoV-2 RBD and scaffold domains from HKU-1 elicits potent neutralising antibody responses
DOI: 10.1038/s41541-025-01323-62025
Journal article
Non-apoptotic caspase-8 is critical for orchestrating exaggerated inflammation during severe SARS-CoV-2 infection
DOI: 10.1038/s41467-025-65098-z2025
Journal article
Combination antiretroviral therapy and MCL-1 inhibition mitigate HTLV-1 infection in vivo
DOI: 10.1016/j.cell.2025.06.0232025
Journal article
IL-1β drives SARS-CoV-2-induced disease independently of the inflammasome and pyroptosis signalling
DOI: 10.1038/s41418-025-01459-x2025
Journal article
A novel PLpro inhibitor improves outcomes in a pre-clinical model of long COVID
DOI: 10.1038/s41467-025-57905-42024
Journal article
mRNA vaccines encoding membrane-anchored RBDs of SARS-CoV-2 mutants induce strong humoral responses and can overcome immune imprinting
DOI: 10.1016/j.omtm.2024.101380
RECENT SCHOLARLY WORKS
2024
Journal article
Human Nasal Epithelium Organoids for Assessing Neutralizing Antibodies to a Protective SARS-CoV-2 Virus-like Particle Vaccine
DOI: 10.3390/organoids30100022024
Journal article
Necroptosis does not drive disease pathogenesis in a mouse infective model of SARS-CoV-2 in vivo
DOI: 10.1038/S41419-024-06471-62023
Journal article
Rapid detection of monkeypox virus using a CRISPR-Cas12a mediated assay: a laboratory validation and evaluation
DOI: 10.1016/S2666-5247(23)00148-9